Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06171724 · ClinicalTrials.gov registry record · Early Phase 1
Ashwagandha Pharmacokinetics Study in Older Adults
A Early Phase 1 study, sponsored by Oregon Health and Science University.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 11
- Enrollment target
NCT06171724 is a Early Phase 1 study that was terminated before completion, run by Oregon Health and Science University. The registered enrollment target is 11 participants.
The verdict
NCT06171724, a Early Phase 1 study, was terminated before completion, sponsored by Oregon Health and Science University.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This study will measure the oral bioavailability and pharmacokinetics of known compounds from a standardized Withania somnifera botanical dietary supplement in healthy older adults.
Interventions
- DIETARY_SUPPLEMENT Shoden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2024-04-08 |
| Est. Completion | 2024-12-09 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06171724
The ClinicalTrials.gov registry entry for NCT06171724 describes a study currently listed as terminated, categorized as Early Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shoden is the first listed.
NCT06171724 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06171724 about?
NCT06171724 is a clinical study titled "Ashwagandha Pharmacokinetics Study in Older Adults". This study will measure the oral bioavailability and pharmacokinetics of known compounds from a standardized Withania somnifera botanical dietary supplement in healthy older adults.
What is the current status of trial NCT06171724?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 11 participants. The study started on 2024-04-08. Estimated completion is 2024-12-09.
What interventions are being tested in trial NCT06171724?
The interventions under investigation include: Shoden (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06171724?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.